Response by Trifan et al to Letter Regarding Article, "efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials"

Gabriela Trifan; Philip B. Gorelick; Fernando D. Testai

doi:10.1161/CIRCULATIONAHA.121.057471

Response by Trifan et al to Letter Regarding Article, "efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials"

Gabriela Trifan, Philip B. Gorelick, Fernando D. Testai

Neurology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	E493-E494
Journal	Circulation
Volume	144
Issue number	24
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.121.057471
State	Published - Dec 14 2021

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1161/CIRCULATIONAHA.121.057471

Cite this

Trifan, G., Gorelick, P. B., & Testai, F. D. (2021). Response by Trifan et al to Letter Regarding Article, "efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials". Circulation, 144(24), E493-E494. https://doi.org/10.1161/CIRCULATIONAHA.121.057471

@article{95d390ce15f7499099380715f6b088ba,

title = "Response by Trifan et al to Letter Regarding Article, {"}efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials{"}",

author = "Gabriela Trifan and Gorelick, {Philip B.} and Testai, {Fernando D.}",

year = "2021",

month = dec,

day = "14",

doi = "10.1161/CIRCULATIONAHA.121.057471",

language = "English (US)",

volume = "144",

pages = "E493--E494",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "24",

}

Trifan, G, Gorelick, PB & Testai, FD 2021, 'Response by Trifan et al to Letter Regarding Article, "efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials"', Circulation, vol. 144, no. 24, pp. E493-E494. https://doi.org/10.1161/CIRCULATIONAHA.121.057471

Response by Trifan et al to Letter Regarding Article, "efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials". / Trifan, Gabriela; Gorelick, Philip B.; Testai, Fernando D.
In: Circulation, Vol. 144, No. 24, 14.12.2021, p. E493-E494.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Response by Trifan et al to Letter Regarding Article, "efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention

T2 - Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials"

AU - Trifan, Gabriela

AU - Gorelick, Philip B.

AU - Testai, Fernando D.

PY - 2021/12/14

Y1 - 2021/12/14

UR - http://www.scopus.com/inward/record.url?scp=85122775062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85122775062&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.121.057471

DO - 10.1161/CIRCULATIONAHA.121.057471

M3 - Letter

C2 - 34898240

AN - SCOPUS:85122775062

SN - 0009-7322

VL - 144

SP - E493-E494

JO - Circulation

JF - Circulation

IS - 24

ER -

Response by Trifan et al to Letter Regarding Article, "efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials"

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this